New SEC Form D filing

StimCardio Medical, Inc., 2026-07-29

A new SEC Form D private-offering notice from Los Angeles, CA, a $25,000,000 filer-stated offering target in Healthcare & health tech. The source filing is one click away.

What this filing says

StimCardio Medical, Inc. site↗ Verified via SEC Form D

Clinical-stage medical device company developing a non-invasive, wearable neuromodulation platform (Rhyvive) for atrial fibrillation treatment

Filed 2026-07-29Filed to raise $25,000,000First money in 2025-11-24Raised so far $24,949,739HQ (as filed) Los Angeles, CASector Healthcare & health tech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified stimcardio.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source